Contact Us
Drug Search Results
More Filters [+]

Tinzaparin sodium

Alternative Names: tinzaparin sodium, tinzaparin, innohep
Latest Update: 2024-11-28
Latest Update Note: Clinical Trial Update

Product Description

Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT) with or without pulmonary embolism (PE) when administered in conjunction with warfarin sodium (Sourced from: https://pubmed.ncbi.nlm.nih.gov/12166042/)

Mechanisms of Action: Thrombin Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Austria | Belgium | Canada | Chile | Colombia | Cyprus | Denmark | Egypt | Finland | France | Germany | Greece | Hong Kong | Ireland | Italy | Jordan | Luxembourg | Malaysia | Morocco | Netherlands | New Zealand | Pakistan | Peru | Philippines | Portugal | Romania | Saudi Arabia | Slovenia | South Africa | Spain | Sweden | Taiwan | Thailand | Tunisia | Turkey | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: LEO Pharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tinzaparin sodium

Countries in Clinic: Spain

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Colorectal Cancer|Thromboembolism

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
PROTINCOL

P3

Active, not recruiting

Colorectal Cancer

2025-03-23

PROTINCOL

P3

Recruiting

Thromboembolism|Colorectal Cancer

2024-12-01

Recent News Events

Date

Type

Title

10/04/2023

News Article

 Low Molecular Weight Heparin Market Overview, Size, Share and Forecast 2031

08/22/2022

News Article

 Global Low Molecular Weight Heparin Market to Surpass US$ 6,539.3 Million by 2030, Says Coherent Market Insights (CMI)

02/11/2022

News Article

 Low Molecular Weight Heparin Market Size Worth $5,733.96 Mn, Globally, by 2028 at 6.6% CAGR - Exclusive Report by The Insight Partners

11/18/2021

News Article

 Cardiac Biomarkers Market to surpass US$ 16,019.9 Mn, globally, by 2028, Says Coherent Market Insights (CMI)

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions